Tricuspid regurgitation risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There are no established risk factors for [disease name]. OR The most potent risk factor in the development of [disease name...") |
|||
| (11 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Tricuspid regurgitation}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of [[tricuspid regurgitation]] include [[Infection|infections]], [[endocarditis]], [[ebstein anomaly]], [[tricuspid valve prolapse]], [[carcinoid]], [[Papillary muscle dysfunction|papillary muscle]] dysfunction and [[medications]]. Most cases of significant [[tricuspid regurgitation]] are due to [[tricuspid]] annular dilation and leaflet tethering secondary to right [[ventricular]] remodeling from volume and/or pressure overload. | |||
==Risk Factors== | ==Risk Factors== | ||
===Common Risk Factors=== | |||
*Common risk factors in the development of [[tricuspid regurgitation]] include:<ref name="pmid17400120">{{cite journal| author=Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y| title=Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. | journal=J Am Soc Echocardiogr | year= 2007 | volume= 20 | issue= 4 | pages= 405-8 | pmid=17400120 | doi=10.1016/j.echo.2006.09.013 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17400120 }}</ref><ref name="pmid18222317">{{cite journal| author=Shah PM, Raney AA| title=Tricuspid valve disease. | journal=Curr Probl Cardiol | year= 2008 | volume= 33 | issue= 2 | pages= 47-84 | pmid=18222317 | doi=10.1016/j.cpcardiol.2007.10.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18222317 }}</ref><ref name="pmid3536106">{{cite journal| author=Waller BF| title=Etiology of pure tricuspid regurgitation. | journal=Cardiovasc Clin | year= 1987 | volume= 17 | issue= 2 | pages= 53-95 | pmid=3536106 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3536106 }}</ref> | |||
**[[Rheumatic heart disease]] | |||
**[[Endocarditis]] is a common risk factor in developing [[tricuspid regurgitation]] due to the following: | |||
***[[Alcoholism]] | |||
***[[Intravenous drug use]] | |||
***[[Cardiac|Cardiac tumours]] | |||
***Indwelling [[Catheter|catheters]] which might get infected | |||
***[[Burn|Burns]] when extensive | |||
* | **[[Tricuspid valve prolapse]] | ||
* | **[[Papillary muscle dysfunction]] | ||
**[ | **[[Right ventricle|RV]] dilatation | ||
**[ | **[[Trauma]] which includes: | ||
**[ | ***[[Right ventricle|Right ventricular]] [[endomyocardial]] [[biopsy]] | ||
***Blunt chest wall [[trauma]] like stab wounds and projectiles | |||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of [ | *Less common [[Risk factor|risk factors]] in the development of [[tricuspid regurgitation]] include: | ||
** | **Pregnant mothers who are using lithium are at a risk for developing ebstein anomaly | ||
** | **Connective-tissue diseases | ||
** | **Medications which include:<ref name="pmid15277624">{{cite journal| author=Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB| title=Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. | journal=Neurology | year= 2004 | volume= 63 | issue= 2 | pages= 301-4 | pmid=15277624 | doi=10.1212/01.wnl.0000129842.49926.07 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15277624 }}</ref><ref name="pmid12479512">{{cite journal| author=Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE| title=Valvular heart disease in patients taking pergolide. | journal=Mayo Clin Proc | year= 2002 | volume= 77 | issue= 12 | pages= 1280-6 | pmid=12479512 | doi=10.4065/77.12.1280 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12479512 }}</ref> | ||
***Fenfluramine | |||
***Phentermine | |||
***Pergolide | |||
==References== | ==References== | ||
Latest revision as of 13:57, 21 April 2020
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation risk factors On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation risk factors |
|
Risk calculators and risk factors for Tricuspid regurgitation risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Common risk factors in the development of tricuspid regurgitation include infections, endocarditis, ebstein anomaly, tricuspid valve prolapse, carcinoid, papillary muscle dysfunction and medications. Most cases of significant tricuspid regurgitation are due to tricuspid annular dilation and leaflet tethering secondary to right ventricular remodeling from volume and/or pressure overload.
Risk Factors
Common Risk Factors
- Common risk factors in the development of tricuspid regurgitation include:[1][2][3]
- Rheumatic heart disease
- Endocarditis is a common risk factor in developing tricuspid regurgitation due to the following:
- Alcoholism
- Intravenous drug use
- Cardiac tumours
- Indwelling catheters which might get infected
- Burns when extensive
- Tricuspid valve prolapse
- Papillary muscle dysfunction
- RV dilatation
- Trauma which includes:
- Right ventricular endomyocardial biopsy
- Blunt chest wall trauma like stab wounds and projectiles
Less Common Risk Factors
- Less common risk factors in the development of tricuspid regurgitation include:
References
- ↑ Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y (2007). "Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation". J Am Soc Echocardiogr. 20 (4): 405–8. doi:10.1016/j.echo.2006.09.013. PMID 17400120.
- ↑ Shah PM, Raney AA (2008). "Tricuspid valve disease". Curr Probl Cardiol. 33 (2): 47–84. doi:10.1016/j.cpcardiol.2007.10.004. PMID 18222317.
- ↑ Waller BF (1987). "Etiology of pure tricuspid regurgitation". Cardiovasc Clin. 17 (2): 53–95. PMID 3536106.
- ↑ Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB (2004). "Pergolide use in Parkinson disease is associated with cardiac valve regurgitation". Neurology. 63 (2): 301–4. doi:10.1212/01.wnl.0000129842.49926.07. PMID 15277624.
- ↑ Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE (2002). "Valvular heart disease in patients taking pergolide". Mayo Clin Proc. 77 (12): 1280–6. doi:10.4065/77.12.1280. PMID 12479512.